Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results

AIM: To assess the real-world effectiveness and cost of simeprevir (SMV), and/or sofosbuvir (SOF)-based therapy for chronic hepatitis C virus (HCV) infection. METHODS: The real-world performance of patients treated with SMV/SOF ± ribavirin (RBV), SOF/RBV, and SOF/RBV with pegylated-interferon (PEG)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Virol
Hauptverfasser: Bichoupan, Kian, Tandon, Neeta, Crismale, James F, Hartman, Joshua, Del Bello, David, Patel, Neal, Chekuri, Sweta, Harty, Alyson, Ng, Michel, Sigel, Keith M, Bansal, Meena B, Grewal, Priya, Chang, Charissa Y, Leong, Jennifer, Im, Gene Y, Liu, Lawrence U, Odin, Joseph A, Bach, Nancy, Friedman, Scott L, Schiano, Thomas D, Perumalswami, Ponni V, Dieterich, Douglas T, Branch, Andrea D
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Inc 2017
Schlagworte:
Observational Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5680347/
https://ncbi.nlm.nih.gov/pubmed/29147645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5501/wjv.v6.i4.59
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge